Texas Capital Bancshares Inc.
TCBIO | NASDAQ
$19.10
-$0.40 (-2.08%)
Sep 22, 2026, 2:30 PM ET · Market open
Market Data
Market Cap $4.22B
Enterprise Value $1.1B
Beta 0.67
Average Volume N/A
Shares Outstanding (Diluted) 46.23M
Shares Change YoY -13.12%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -2.6%
1Y CAGR (ann.) -2.9%
5Y CAGR (ann.) 0.8%
All-Time CAGR 2.9%
Valuation
PE Ratio 3.19
Forward PE 11.04
PEG Ratio 0.06
Forward PEG 0.98
PS Ratio 2.12
Forward PS 2.90
PB Ratio 1.16
P/FCF Ratio 10.97
P/Adj. FCF Ratio 11.91
P/OCF Ratio 0.95
EV/Sales 0.55
EV/EBIT 2.79
EV/EBITDA 2.54
EV/FCF 2.86
Earnings Yield 31.3%
FCF Yield 9.1%
Adj. FCF Yield 8.4%
Financial Health
Net Cash $3.12B
Total Debt $895.42M
Cash & Short-Term Investments $4.01B
Total Assets $32.54B
Current Ratio 26.12
Quick Ratio 26.12
Debt / Equity Ratio 0.23
Debt / EBITDA 2.07
Debt / FCF 2.33
OCF / Debt 0.46
Interest Coverage 0.69
Altman Z-Score 0.63
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 62.4%
Operating Profit Margin 19.8%
EBITDA Margin 27.6%
Net Profit Margin 18.6%
FCF Margin 19.4%
Adj. FCF Margin 17.8%
SBC / Revenue 1.6%
SBC Impact (per share) -7.9%
Returns
Return on Assets 1.1%
Return on Equity 10.0%
Return on Invested Capital 1.1%
Return on Capital Employed 1.4%
Return on Tangible Assets 1.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 21.9%
Revenue CAGR 5Y 9.7%
Revenue CAGR 10Y 12.1%
EPS CAGR 3Y 23.9%
EPS CAGR 5Y 34.5%
EPS CAGR 10Y 7.4%
FCF CAGR 3Y 2.9%
FCF CAGR 5Y -17.0%
FCF CAGR 10Y 7.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Oct 20, 2026
EPS Estimate (next Q) $1.95
EPS Growth Est (next Q) -14.5%
Revenue Est (next Q) $339.06M
Revenue Growth Est (next Q) -26.4%
Fair Value Estimates
Graham Number $105.54
Graham Upside 441.2%
Lynch Fair Value $152.75
Lynch Upside 683.3%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow $415.02M
Free Cash Flow $384.47M
Adj. Free Cash Flow $354.15M
FCF Per Share $20.57
OCF Per Share $20.45
OCF/S Ratio 46.9%
Income Statement
Revenue $1.99B
Gross Profit $821.62M
Operating Income $393.95M
EBITDA $432.93M
Net Income $300.61M
EPS (Diluted) $6.11
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Dividends
Annual Dividend $1.44
Dividend Yield 7.38%
Payout Ratio 23.5%
FCF Payout Ratio 4.5%
Adj. FCF Payout Ratio 4.9%
Dividend Growth (YoY) 0.0%
Pay Frequency Quarterly
Ex-Dividend Date Aug 31, 2026
Add to Watchlist
Select watchlists to add or remove TCBIO